This inventor holds 1 USPTO granted patent. Top assignee: Actavis Group Ptc Ehf. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Munusamy Jayamani: Innovator in Pharmaceutical Processes
Introduction
Munusamy Jayamani is a notable inventor based in Chennai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes that enhance the efficiency of drug production. His work is characterized by a focus on improving yield and reducing reaction time in chemical processes.
Latest Patents
Jayamani holds a patent for the "Process for preparation of 9-hydroxy-3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-A]pyrimidin-4-one hydrochloride." This patent describes an improved, commercially viable, and industrially advantageous process for preparing the paliperidone intermediate. The process not only provides the intermediate in higher yield but also reduces the reaction time compared to previously disclosed methods. This advancement allows for the production of paliperidone and its pharmaceutically acceptable acid addition salts in high purity and yield.
Career Highlights
Jayamani is associated with Actavis Group Ptc Ehf, where he applies his expertise in pharmaceutical processes. His innovative approach has contributed to the company's reputation for developing effective and efficient drug manufacturing techniques.
Collaborations
Throughout his career, Jayamani has collaborated with talented individuals such as Uday Rajaram Bapat and Vigneshwara Ravisankar. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective fields.
Conclusion
Munusamy Jayamani's contributions to pharmaceutical processes exemplify the impact of innovation in drug development. His patented process not only enhances production efficiency but also underscores the importance of continuous improvement in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile